2021 IPO

Pear Therapeutics Stock

Digital Therapeutics Platform

Sign up today and learn more about Pear Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Trustbridge Partners


Boston MA, US

Total Funding


About Pear Therapeutics Stock

Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to help treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia. 

Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts. Notable investors include Softbank Vision Fund, Temasek Holdings, and Perceptive Advisors.


Funding History

February 2016$18.7M
December 2017$51.0M
December 2018$64.4M
December 2020$32.0M
December 2020$107M


Chief Executive Officer

Corey McCann

Chief Financial Officer

Chris Guiffre


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: